B. Mark Evers, MD
B. Mark Evers, MD, associate director, Center for Clinical and Translational Science, Markey Cancer Center, holding the Markey Cancer Foundation Endowed Chair; professor and vice-chair for research, Department of Surgery; and Physician-in-Chief, Oncology Service Line. Dr. Evers is an internationally recognized clinician-scientist, surgeon, educator and administrator. His laboratory research has been continuously funded for 17 years from the National Institutes of Health with primary interests on signaling mechanisms for proliferation of colorectal cancers. His laboratory was the first to demonstrate a role for PI3K inhibition in intestinal differentiation. He has explored the experimental use of novel therapies, including RNA interference of PI3K components to demonstrate colorectal cancer suppression and enhanced sensitivity to standard chemotherapeutic agents.
Currently, Dr. Evers has 4 R01s, including a MERIT award. In addition, he is director of a Specialized Program of Research Excellence (SPORE) grant for GI cancer as well as a project leader and core director on a Program Project grant. Dr. Evers has been recognized for his research achievements, including election to the American Society for Clinical Investigation; he has held leadership positions in various national societies, including the Society for Surgical Oncology, American College of Surgeons, the American Gastroenterological Association and the Society of University Surgeons. He is a past president of the Society of University Surgeons, a current director of the American Board of Surgery, and secretary of the Southern Surgical Association. Dr. Evers is a regular member of the Tumor and Microenvironment (TME) study section.
Dr. Evers is a recognized leader and champion for the surgical scientist and has spearheaded efforts through various surgical organizations such as the Society of University Surgeons and the American College of Surgeons to further stimulate and enhance the number of junior faculty who choose academic careers as surgeon scientists. He has devoted much of his academic career to mentoring and nurturing the next generation of clinician scientists, as well as fostering the careers of basic researchers by exposing them to clinical problems.